ARTICLE | Company News
Debiopharm, Ascepion in cancer deal
June 19, 2012 1:48 AM UTC
Ascepion Pharmaceuticals Inc. (Suzhou, China) granted Debiopharm Group (Lausanne, Switzerland) exclusive, worldwide rights to develop and commercialize Debio 1144 (formerly ASP-08126). The oral small ...